Xalatan® is a prostanoid selective FP receptor agonist that reduces the intraocular pressure. Xalatan® is thought to lower the intraocular pressure by increasing the out flow of the fluid inside the eye (aqueous humor) through the trabecular meshwork and uveoscleral tissue. In clinical studies of patients with open angle glaucoma with an average starting intraocular pressure of 24-25 mmHg, the average pressure lowering effect of Xalatan® was 6-8 mmHg
.jpg)
